Lymph node dissection in malignant melanoma;Lymphknotendissektionen beim malignen melanom

Chirurg

Volumn 67, Issue 8, 1996, Pages 779-787

  Hohenberger, W ^a   Gohl J ^a   Altendorf Hofmann, A ^a   Meyer, Th ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Lymph node dissection; Lymph node metastases; Malignant melanoma; Prognosis

Indexed keywords

CANCER STAGING; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; METHODOLOGY; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SKIN TUMOR; SURVIVAL RATE;

FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0030208987     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002518     Document Type: Article

References (24)

1. Bachter D, Balda BR, Vogt H, Büchels H (1996) Die "sentinel" Lymphonodektomie mittels Szintillationsdetektor - eine neue Strategie in der Behandlung maligner Melanome. Hautarzt, im Druck
2. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA (1981) A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (stage II) Ann Surg 193: 377
3. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA (1992) Analysis of prognostic factors in 8500 patients with cutaneous melanoma In: Hrsg.: Balch CM, Houghton AN, Milton GW, Soober AJ, Soong SJ (eds) Cutaneous melanoma, 2nd edn. Lippincott, Philadelphia, p 165
4. Balch CM, Milton GW, Cascinelli N, Sim FH (1992) Elective lymph node dissection: pros and cons. In: Balch CM, Houghton AN, Milton GW, Soober AJ, Soong SJ (eds) Cutaneous melanoma, 2nd edn. Lippincott, Philadelphia, p 345
5. Balch CM, Houghton AN (1992) Diagnosis of metastatic melanoma at distant sites. In: Balch CM, Houghton AN, Milton GW, Soober AJ, Soong SJ (eds) Cutaneous melanoma, 2nd edn. Lippincott, Philadelphia, p 439
6. Binder M, Pehamberger H, Steiner A, Wolff K (1990) Elective regional lymph node disection in malignant melanoma. Eur J Cancer 26: 871
7. Blois MS, Sagebiel RW, Tuttle MS, Caldwell TM, Taylor HW (1983) Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets. Ann Surg 198: 200
8. Cascinelli N, Bufalino R, Morabito A, MacKie R (1994) Results of adjuvant interferon study in WHO melanoma programme. Lancet 343: 913
9. Drepper H, Köhler CO, Bastian B, Breuninger H, et al (1994) Prognosevorteil für definierte Risikogruippen durch die Lymphknotendissektion. Langzeitstudie an 3616 Melanompatienten. Hautarzt 45: 615
10. Drepper H, Köhler CO, Bastian B, Breuninger H, et al (1993) Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer 72: 741
11. Garbe C (1995) Adjuvant vindesine and interferon-beta in malignant melanoma. Vortrag 1st International Conference "The Adjuvant Therapy of Malignant Melanoma", 25-25 March 1995, Royal Society of Medicine, London, A12
12. Hermanek P, Blinov NN (1995) Malignant melanoma of the skin. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognostic factors in cancer. Springer, Berlin Heidelberg NewYork, p 153
13. Hohenberger W, Göhl J, Hermanek P, Schell H (1989) Behandlungsergebnisse von pT 3/4-Melanomen (klinisches Stadium I) mit elektiver Lymphknoten-Dissektion. Hautarzt 40: 377
14. Hohenberger W, Göhl J, Kessler Ch (1993) Prophylaktische und therapeutische Lymphknotendissektion bei malignem Melanom. Chirurg BDC 32: 7
15. Illig L, Aigner KR, Biess B, Göhl J, et al (1988) Diagnostic excision of the Rosenmüller's node. Screening for occult metastases before elective regional lymph node dissection in patients with lower limb melanoma? Cancer 61: 1200
16. Krag DN, Meijer SJ, Weaver DL, Loggie BW, et al (1995) Minimal-access surgery for staging malignant melanoma. Arch Surg 130: 654
17. Morton DL, Wen DR, Wong JH, Economou JS, et al (1992) Technical details of intraoperative mapping for early stage melanoma. Arch Surg 127: 392
18. Reintgen D, Cruse CW, Wells K, Berman C, et al (1994) The orderly progression of melanoma nodal metastases. Ann Surg 220: 759
19. Retsas S, Quigley M, Pectasides D, MaCrae K, Henry K (1994) Clinical and histological involvement of regional lymph nodes in malignant melanoma: adjuvant vindesine improves survival. Cancer 73: 2119
20. Sim FH, Tayor WF, Ivins JC, Pritchard DJ, Soul EH (1978) A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 41: 948
21. Soong SJ (1992) A computerized mathematical model and scoring system for predicting outcome in patients with localized melanoma. In: In: Balch CM, Houghton AN, Milton GW, Soober AJ, Soong SJ (eds) Cutaneous melanoma, 2nd edn. Lippincott, Philadelphia, p 200
22. UICC (1992) TNM classification of malignant tumours, 4th edn, 2nd revision (Hermanek P, Sobin LH, eds). Springer, Berlin Heidelberg New York
23. Veronesi U, Adamus J, Bandiera DC (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49: 2420
24. Wong JH, Cagle LA, Morton DL (1987) Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site. Arch Surg 122: 1380